During the past decade, Aou Senese - Uoc Ematologia E Trapianti conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aou Senese - Uoc Ematologia E Trapianti" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator and "GRADE Onlus" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Aou Senese - Uoc Ematologia E Trapianti" are "Chronic Lymphocytic Leukemia" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Chronic Myeloid Leukemia" (3 trials), "Acute Lymphoid Leukemia" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Aou Senese - Uoc Ematologia E Trapianti" in a lesser frequency.

Most popular intervention types in "Aou Senese - Uoc Ematologia E Trapianti" are "Drug" (31 trials), "Other" (9 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Imatinib" (3 trials), "Nilotinib" (3 trials), "Cyclophosphamide" (2 trials), "Lenalidomide" (2 trials) and "Ponatinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aou Senese - Uoc Ematologia E Trapianti" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Aou Senese - Uoc Ematologia E Trapianti". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Aou Senese - Uoc Ematologia E Trapianti, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aou Senese - Uoc Ematologia E Trapianti, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".